<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01040702</url>
  </required_header>
  <id_info>
    <org_study_id>SH-40107</org_study_id>
    <nct_id>NCT01040702</nct_id>
  </id_info>
  <brief_title>The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults</brief_title>
  <official_title>The Effect of Methylphenidate on Decision-making Ability of ADHD Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shalvata Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shalvata Mental Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the effect of Methylphenidate on cognitive performance and
      decision-making ability of ADHD adults, and to compare this effect to the effect on healthy
      control adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two matched groups of adults - with and without ADHD diagnosis - will perform a battery of
      computerized tasks assessing sustained attention,working-memory,non-verbal IQ,and
      decision-making ability. In each group,half of the participants will perform the tasks after
      receiving a capsule containing methylphenidate (MPH), and the other half will perform the
      tasks after receiving placebo. Task performance measures will then be compared in order to
      assess the effect of MPH on these domains.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>score in decision-making task 1</measure>
    <time_frame>by the end of the task</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>working memory task score</measure>
    <time_frame>by the end of the task</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>ADHD -MPH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adults with ADHD diagnosis who receive a single dose of Methylphenidate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADHD-placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>adults with ADHD diagnosis who received placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-ADHD-MPH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy adults who received a single dose of Methylphenidate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-ADHD-placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>healthy adults who received placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylphenidate</intervention_name>
    <description>a single doses of 10-20 mg in each one of two visits</description>
    <arm_group_label>ADHD -MPH</arm_group_label>
    <arm_group_label>non-ADHD-MPH</arm_group_label>
    <other_name>Ritalin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>sweetener pill</intervention_name>
    <description>a capsule containing a sweetener pill</description>
    <arm_group_label>ADHD-placebo</arm_group_label>
    <arm_group_label>non-ADHD-placebo</arm_group_label>
    <other_name>sukrazit</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults in the age of 21-50

        Exclusion Criteria:

          -  pregnant or nursing women.

          -  people who suffer from a psychiatric disorder other than ADHD which could account for
             their inattention symptoms better than ADHD.

          -  people who lack judgment or are unable to communicate with the experimenters.

          -  people who are incapable of performing the computerized tasks due to sensory or motor
             disabilities.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziv Carmel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>cognitive laboratory,Shalvata MHC</name>
      <address>
        <city>Hod Hasharon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2009</study_first_submitted>
  <study_first_submitted_qc>December 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2009</study_first_posted>
  <last_update_submitted>December 29, 2009</last_update_submitted>
  <last_update_submitted_qc>December 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ziv Carmel,MD</name_title>
    <organization>Shalvata MHC</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylphenidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

